<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39337571</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>18</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>19</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>CD68-Negative Histiocytoses with Cardiac Involvement, Associated with COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10086</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms251810086</ELocationID><Abstract><AbstractText>Histiocytoses are rare diseases characterised by infiltration of affected organs by myeloid cells with a monocyte or dendritic cell phenotype. Symptoms can range from self-resolving localised forms to multisystemic lesions requiring specific treatment. To demonstrate extremely rare cases of CD68-negative cardiac histiocytosis with expression of SARS-CoV-2 antigen in infiltrate cells. We demonstrated a case of Erdheim-Chester disease in a 67-year-old man with pericardial involvement and positive dynamics with vemurafenib treatment, an autopsy case of xanthogranulomatous myopericarditis in a 63-year-old man, surgical material of xanthogranulomatous constrictive pericarditis in a 57-year-old man, and an autopsy case of xanthogranulomatosis in a 1-month-old girl. In all cases, xanthogranuloma cells expressed CD163, many of them spike protein SARS-CoV-2, while CD68 expression was detected only in single cells. In this article, we demonstrated four cases of extremely rare CD68-negative cardiac xanthogranulomatosis in three adults and one child with expression of the spike protein SARS-CoV-2 in M2 macrophages. This potential indirect association between COVID-19 and the development of histiocytosis in these patients warrants further investigation. To substantiate this hypothesis, more extensive research is needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mitrofanova</LastName><ForeName>Lubov</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korneva</LastName><ForeName>Lubov</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makarov</LastName><ForeName>Igor</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-6175-8403</Identifier><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bortsova</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sitnikova</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryzhkova</LastName><ForeName>Daria</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kudlay</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1878-4467</Identifier><AffiliationInfo><Affiliation>Department of Pharmacognosy and Industrial Pharmacy, Faculty of Fundamental Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Immunology, 115478 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Starshinova</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9023-6986</Identifier><AffiliationInfo><Affiliation>Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Mathematics and Computer Science, St-Petersburg State University, 199034 St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>075-15-2022-301</GrantID><Agency>Almazov National Medical Research Centre of the Ministry of Health of Russian Federation</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015214">Antigens, Differentiation, Myelomonocytic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C067980">CD68 antigen, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C085464">CD163 antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000097382">CD68 Molecule</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011956">Receptors, Cell Surface</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015214" MajorTopicYN="Y">Antigens, Differentiation, Myelomonocytic</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015703" MajorTopicYN="Y">Antigens, CD</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015614" MajorTopicYN="Y">Histiocytosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D031249" MajorTopicYN="N">Erdheim-Chester Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000097382" MajorTopicYN="N">CD68 Molecule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011956" MajorTopicYN="N">Receptors, Cell Surface</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD68</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Erdheimâ€“Chester disease</Keyword><Keyword MajorTopicYN="N">myocarditis</Keyword><Keyword MajorTopicYN="N">pericarditis</Keyword><Keyword MajorTopicYN="N">xanthogranulomatosis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39337571</ArticleId><ArticleId IdType="pmc">PMC11432257</ArticleId><ArticleId IdType="doi">10.3390/ijms251810086</ArticleId><ArticleId IdType="pii">ijms251810086</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gurieva O.D., Valiev T.T., Pavlovskaya A.I. Histiocytic neoplasms: Modern aspects of pathogenesis, classification, diagnosis and treatment. Oncohematology. 2022;17:10â€“25. doi: 10.17650/1818-8346-2022-17-1-10-25.</Citation><ArticleIdList><ArticleId IdType="doi">10.17650/1818-8346-2022-17-1-10-25</ArticleId></ArticleIdList></Reference><Reference><Citation>Emile J.F., Abla O., Fraitag S., Horne A., Haroche J., Donadieu J., Requena-Caballero L., Jordan M.B., Abdel-Wahab O., Allen C.E., et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127:2672â€“2681. doi: 10.1182/blood-2016-01-690636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2016-01-690636</ArticleId><ArticleId IdType="pmc">PMC5161007</ArticleId><ArticleId IdType="pubmed">26966089</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen C.E., Merad M., McClain K.L. Langerhans-Cell Histiocytosis. N. Engl. J. Med. 2018;379:856â€“868. doi: 10.1056/NEJMra1607548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1607548</ArticleId><ArticleId IdType="pmc">PMC6334777</ArticleId><ArticleId IdType="pubmed">30157397</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen C.E., Ladisch S., McClain K.L. How I treat Langerhans cell histiocytosis. Blood. 2015;126:26â€“35. doi: 10.1182/blood-2014-12-569301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2014-12-569301</ArticleId><ArticleId IdType="pmc">PMC4492195</ArticleId><ArticleId IdType="pubmed">25827831</ArticleId></ArticleIdList></Reference><Reference><Citation>Romani N., Clausen B.E., Stoitzner P. Langerhans cells and more: Langerin-expressing dendritic cell subsets in the skin. Immunol. Rev. 2010;234:120â€“141. doi: 10.1111/j.0105-2896.2009.00886.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0105-2896.2009.00886.x</ArticleId><ArticleId IdType="pmc">PMC2907488</ArticleId><ArticleId IdType="pubmed">20193016</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen C.E., Li L., Peters T.L., Leung H.-C.E., Yu A., Man T.-K., Gurusiddappa S., Phillips M.T., Hicks M.J., Gaikwad A., et al. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J. Immunol. 2010;184:4557â€“4567. doi: 10.4049/jimmunol.0902336.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0902336</ArticleId><ArticleId IdType="pmc">PMC3142675</ArticleId><ArticleId IdType="pubmed">20220088</ArticleId></ArticleIdList></Reference><Reference><Citation>Badalian-Very G., Vergilio J.A., Degar B.A., MacConaill L.E., Brandner B., Calicchio M.L., Kuo F.C., Ligon A.H., Stevenson K.E., Kehoe S.M., et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116:1919â€“1923. doi: 10.1182/blood-2010-04-279083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2010-04-279083</ArticleId><ArticleId IdType="pmc">PMC3173987</ArticleId><ArticleId IdType="pubmed">20519626</ArticleId></ArticleIdList></Reference><Reference><Citation>Krylov A.S., Dolgushin M.B., Ryzhkov A.D., Odzharova A.A., Shchipakhina Y.A., Sushentsov E.A., Bliznyukov O.P., Kaspshik S.M., Martinovich A.A., Stroganova A.M., et al. Erdheimâ€“Chester disease. Literature review and clinical case. Oncohematology. 2020;15:61â€“75. doi: 10.17650/1818-8346-2020-15-2-61-75.</Citation><ArticleIdList><ArticleId IdType="doi">10.17650/1818-8346-2020-15-2-61-75</ArticleId></ArticleIdList></Reference><Reference><Citation>Emile J.F., Charlotte F., Amoura Z., Haroche J. BRAF mutations in Erdheim-Chester disease. J. Clin. Oncol. 2013;31:398. doi: 10.1200/JCO.2012.46.9676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2012.46.9676</ArticleId><ArticleId IdType="pubmed">23248255</ArticleId></ArticleIdList></Reference><Reference><Citation>Emile J.F., Diamond E.L., HÃ©lias-Rodzewicz Z., Cohen-Aubart F., Charlotte F., Hyman D.M., Kim E., Rampal R., Patel M., Ganzel C., et al. Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease. Blood. 2014;124:3016â€“3019. doi: 10.1182/blood-2014-04-570937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2014-04-570937</ArticleId><ArticleId IdType="pmc">PMC4224196</ArticleId><ArticleId IdType="pubmed">25150293</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond E.L., Abdel-Wahab O., Pentsova E., Borsu L., Chiu A., Teruya-Feldstein J., Hyman D.M., Rosenblum M. Detection of an NRAS mutation in Erdheim-Chester disease. Blood. 2013;122:1089â€“1091. doi: 10.1182/blood-2013-02-482984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2013-02-482984</ArticleId><ArticleId IdType="pubmed">23929840</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas D., Richards J.C., Ocazionez D., Sirajuddin A., Browne L., Restrepo C.S. Cardiothoracic manifestations of primary histiocytoses. Br. J. Radiol. 2016;89:20160347. doi: 10.1259/bjr.20160347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1259/bjr.20160347</ArticleId><ArticleId IdType="pmc">PMC5604911</ArticleId><ArticleId IdType="pubmed">27603510</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnaud L., Gorochov G., Charlotte F., Lvovschi V., Parizot C., Larsen M., Ghillani-Dalbin P., Hervier B., Kahn J.-E., Deback C., et al. Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: A single-center series of 37 patients. Blood. 2011;117:2783â€“2790. doi: 10.1182/blood-2010-10-313510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2010-10-313510</ArticleId><ArticleId IdType="pubmed">21205927</ArticleId></ArticleIdList></Reference><Reference><Citation>Haroche J., Arnaud L., Amoura Z. Erdheim-Chester disease. Curr. Opin. Rheumatol. 2012;24:53â€“59. doi: 10.1097/BOR.0b013e32834d861d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0b013e32834d861d</ArticleId><ArticleId IdType="pubmed">22089098</ArticleId></ArticleIdList></Reference><Reference><Citation>Collin M. Histiocytes set on the heart: Cardiac complications of Erdheim-Chester disease. Eur. Heart J. 2023;44:2386â€“2387. doi: 10.1093/eurheartj/ehac769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac769</ArticleId><ArticleId IdType="pmc">PMC10327874</ArticleId><ArticleId IdType="pubmed">36806928</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponsiglione A., Puglia M., Barbuto L., Solla R., Altiero M., Lubrano V., Imbriaco M. Cardiac involvement in Erdheim- Chester disease: MRI findings and literature revision. Acta Radiol. Open. 2015;4:2058460115592273. doi: 10.1177/2058460115592273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2058460115592273</ArticleId><ArticleId IdType="pmc">PMC4563377</ArticleId><ArticleId IdType="pubmed">26405559</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehner L.P. Juvenile xanthogranulomas in the first two decades of life: A clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am. J. Surg. Pathol. 2003;27:579â€“593. doi: 10.1097/00000478-200305000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000478-200305000-00003</ArticleId><ArticleId IdType="pubmed">12717244</ArticleId></ArticleIdList></Reference><Reference><Citation>Meidaninikjeh S., Sabouni N., Marzouni H.Z., Bengar S., Khalili A., Jafari R. Monocytes and macrophages in COVID-19: Friends and foes. Life Sci. 2021;269:119010. doi: 10.1016/j.lfs.2020.119010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.119010</ArticleId><ArticleId IdType="pmc">PMC7834345</ArticleId><ArticleId IdType="pubmed">33454368</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohnacker S., Hartung F., Henkel F., Quaranta A., Kolmert J., Priller A., Ud-Dean M., Giglberger J., Kugler L.M., Pechtold L., et al. Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages. Mucosal Immunol. 2022;15:515â€“524. doi: 10.1038/s41385-021-00482-8. Erratum in Mucosal Immunol. 2022, 15, 798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-021-00482-8</ArticleId><ArticleId IdType="pmc">PMC9038526</ArticleId><ArticleId IdType="pubmed">35288643</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S.R., Ramelli S.C., Grazioli A., Chung J.-Y., Singh M., Yinda C.K., Winkler C.W., Sun J., Dickey J.M., Ylaya K., et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758â€“763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z.E., Li J.J., Sheng K., Liu R., Fan F., Zhou L.-M., Zhang H., Hao D.-L. A case report of Erdheim-Chester disease-clinically characterized by recurrent fever, multiple bone destruction, and antinuclear antibodies. Heliyon. 2023;9:e18867. doi: 10.1016/j.heliyon.2023.e18867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e18867</ArticleId><ArticleId IdType="pmc">PMC10440471</ArticleId><ArticleId IdType="pubmed">37609395</ArticleId></ArticleIdList></Reference><Reference><Citation>Matzumura M., Arias-Stella J., 3rd, Novak J.E. Erdheim-Chester Disease: A Rare Presentation of a Rare Disease. J. Investig. Med. High Impact Case Rep. 2016;4:2324709616663233. doi: 10.1177/2324709616663233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2324709616663233</ArticleId><ArticleId IdType="pmc">PMC4997308</ArticleId><ArticleId IdType="pubmed">27606325</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottfried E., Kunz-Schughart L.A., Weber A., Rehli M., Peuker A., MÃ¼ller A., Kastenberger M., Brockhoff G., Andreesen R., Kreutz M. Expression of CD68 in non-myeloid cell types. Scand. J. Immunol. 2008;67:453â€“463. doi: 10.1111/j.1365-3083.2008.02091.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3083.2008.02091.x</ArticleId><ArticleId IdType="pubmed">18405323</ArticleId></ArticleIdList></Reference><Reference><Citation>Chistiakov D.A., Killingsworth M.C., Myasoedova V.A., Orekhov A.N., Bobryshev Y.V. CD68/macrosialin: Not just a histochemical marker. Lab. Investig. 2017;97:4â€“13. doi: 10.1038/labinvest.2016.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2016.116</ArticleId><ArticleId IdType="pubmed">27869795</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L., Lee C., Schindler C. Deletion of the murine scavenger receptor CD68. J. Lipid Res. 2011;52:1542â€“1550. doi: 10.1194/jlr.M015412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M015412</ArticleId><ArticleId IdType="pmc">PMC3137020</ArticleId><ArticleId IdType="pubmed">21572087</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn T.A., Vannella K.M. Macrophages in Tissue Repair, Regeneration, and Fibrosis. Immunity. 2016;44:450â€“462. doi: 10.1016/j.immuni.2016.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2016.02.015</ArticleId><ArticleId IdType="pmc">PMC4794754</ArticleId><ArticleId IdType="pubmed">26982353</ArticleId></ArticleIdList></Reference><Reference><Citation>Makarov I., Voronkina D., Gurshchenkov A., Ryzhkov A., Starshinova A., Kudlay D., Mitrofanova L. Are Endomyocardial Ventricular Biopsies Useful for Assessing Myocardial Fibrosis? J. Clin. Med. 2024;13:3275. doi: 10.3390/jcm13113275.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13113275</ArticleId><ArticleId IdType="pmc">PMC11172522</ArticleId><ArticleId IdType="pubmed">38892986</ArticleId></ArticleIdList></Reference><Reference><Citation>Bost P., Giladi A., Liu Y., Bendjelal Y., Xu G., David E., Blecher-Gonen R., Cohen M., Medaglia C., Li H., et al. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients. Cell. 2020;181:1475â€“1488.e12. doi: 10.1016/j.cell.2020.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.006</ArticleId><ArticleId IdType="pmc">PMC7205692</ArticleId><ArticleId IdType="pubmed">32479746</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant R.A., Morales-Nebreda L., Markov N.S., Swaminathan S., Querrey M., Guzman E.R., Abbott D.A., Donnelly H.K., Donayre A., Goldberg I.A., et al. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. Nature. 2021;590:635â€“641. doi: 10.1038/s41586-020-03148-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-03148-w</ArticleId><ArticleId IdType="pmc">PMC7987233</ArticleId><ArticleId IdType="pubmed">33429418</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya M. Insights from Transcriptomics: CD163+ Profibrotic Lung Macrophages in COVID-19. Am. J. Respir. Cell Mol. Biol. 2022;67:520â€“527. doi: 10.1165/rcmb.2022-0107TR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2022-0107TR</ArticleId><ArticleId IdType="pmc">PMC9651197</ArticleId><ArticleId IdType="pubmed">35675555</ArticleId></ArticleIdList></Reference><Reference><Citation>Makarov I., Mayrina S., Makarova T., Karonova T., Starshinova A., Kudlay D., Mitrofanova L. Morphological Changes in the Myocardium of Patients with Post-Acute Coronavirus Syndrome: A Study of Endomyocardial Biopsies. Diagnostics. 2023;13:2212. doi: 10.3390/diagnostics13132212.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13132212</ArticleId><ArticleId IdType="pmc">PMC10341165</ArticleId><ArticleId IdType="pubmed">37443606</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y.J., Huang Q.M., Ren Y., Liu Z.-L., Xu C.-F., Wang H., Xiao J.-W. Non-coding RNA in drug resistance of gastric cancer. World J. Gastrointest. Oncol. 2019;11:957â€“970. doi: 10.4251/wjgo.v11.i11.957.</Citation><ArticleIdList><ArticleId IdType="doi">10.4251/wjgo.v11.i11.957</ArticleId><ArticleId IdType="pmc">PMC6883183</ArticleId><ArticleId IdType="pubmed">31798777</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudlay D., Kofiadi I., Khaitov M. Peculiarities of the T cell immune response in COVID-19. Vaccines. 2022;10:242. doi: 10.3390/vaccines10020242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10020242</ArticleId><ArticleId IdType="pmc">PMC8877307</ArticleId><ArticleId IdType="pubmed">35214700</ArticleId></ArticleIdList></Reference><Reference><Citation>Savchenko A.A., Kudlay D.A., Kudryavtsev I.V., Kasparov E.V., Golovkin A.S., Prodeus A.P., Borisov A.G. Clinical Immunology for Practitioners. AS-KIT; Krasnoyarsk, Russia: 2023. Technology of immunometabolic therapy.454p</Citation></Reference><Reference><Citation>Quinaglia-Silva T., Medina F., Ramos C.D., Coelho-Filho O.R. Cardiac Involvement in Erdheim-Chester Disease. Circ. Cardiovasc. Imaging. 2018;11:e008531. doi: 10.1161/CIRCIMAGING.118.008531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.118.008531</ArticleId><ArticleId IdType="pubmed">30562109</ArticleId></ArticleIdList></Reference><Reference><Citation>Salama H., Fahed Alzayed M., Alharbi K.G., Khattak Z., Omer M.H., Tahir L., ALhejazi A. Erdheim-Chester Disease Successfully Treated with Front-Line Single-Agent Dabrafenib. Am. J. Case Rep. 2022;23:e935090. doi: 10.12659/AJCR.935090.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.935090</ArticleId><ArticleId IdType="pmc">PMC8861977</ArticleId><ArticleId IdType="pubmed">35171900</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi D., Delius R.E., Debelenko L.V., Aggarwal S. Cardiac juvenile xanthogranuloma in an infant presenting with pericardial effusion. Congenit. Heart Dis. 2013;8:E106â€“E110. doi: 10.1111/j.1747-0803.2012.00688.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1747-0803.2012.00688.x</ArticleId><ArticleId IdType="pubmed">22691125</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo T.K., Chang K.C., Chu C.B., Lee J.Y.Y. CD68-negative nonlipidized juvenile xanthogranuloma. Dermatol. Sin. 2017;35:142â€“144. doi: 10.1016/j.dsi.2017.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsi.2017.01.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehrke H.D., Johnson C.K., Zapolanski A., Kasatki A., Grau J.B., Maleszewski J.J. Intracardiac juvenile xanthogranuloma with presentation in adulthood. Cardiovasc. Pathol. 2014;23:54â€“56. doi: 10.1016/j.carpath.2013.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carpath.2013.08.002</ArticleId><ArticleId IdType="pubmed">24012116</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolte A.D., Larsen B.T., Sobonya R.E., Al-Amoodi M.A., Khalpey Z.I. Recurrent Intracardiac Juvenile Xanthogranuloma in an Adult. Ann. Thorac. Surg. 2019;107:e285. doi: 10.1016/j.athoracsur.2018.09.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2018.09.069</ArticleId><ArticleId IdType="pubmed">30447189</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>